| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent conferring tensile strength | 1.05e-14 | 46 | 19 | 7 | GO:0030020 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 2.69e-10 | 188 | 19 | 7 | GO:0005201 | |
| GeneOntologyMolecularFunction | structural molecule activity | 1.08e-05 | 891 | 19 | 7 | GO:0005198 | |
| GeneOntologyMolecularFunction | platelet-derived growth factor binding | 5.63e-05 | 12 | 19 | 2 | GO:0048407 | |
| GeneOntologyBiologicalProcess | collagen-activated tyrosine kinase receptor signaling pathway | 1.22e-07 | 12 | 18 | 3 | GO:0038063 | |
| GeneOntologyBiologicalProcess | collagen-activated signaling pathway | 4.52e-07 | 18 | 18 | 3 | GO:0038065 | |
| GeneOntologyBiologicalProcess | extracellular matrix organization | 5.52e-07 | 377 | 18 | 6 | GO:0030198 | |
| GeneOntologyBiologicalProcess | extracellular structure organization | 5.61e-07 | 378 | 18 | 6 | GO:0043062 | |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | 5.70e-07 | 379 | 18 | 6 | GO:0045229 | |
| GeneOntologyBiologicalProcess | positive regulation of neurotransmitter secretion | 2.13e-04 | 25 | 18 | 2 | GO:0001956 | |
| GeneOntologyBiologicalProcess | positive regulation of neurotransmitter transport | 3.51e-04 | 32 | 18 | 2 | GO:0051590 | |
| GeneOntologyCellularComponent | collagen trimer | 5.63e-13 | 88 | 18 | 7 | GO:0005581 | |
| GeneOntologyCellularComponent | complex of collagen trimers | 5.20e-12 | 21 | 18 | 5 | GO:0098644 | |
| GeneOntologyCellularComponent | endoplasmic reticulum lumen | 1.42e-10 | 332 | 18 | 8 | GO:0005788 | |
| GeneOntologyCellularComponent | collagen type IV trimer | 1.07e-08 | 6 | 18 | 3 | GO:0005587 | |
| GeneOntologyCellularComponent | basement membrane collagen trimer | 2.99e-08 | 8 | 18 | 3 | GO:0098651 | |
| GeneOntologyCellularComponent | network-forming collagen trimer | 2.99e-08 | 8 | 18 | 3 | GO:0098642 | |
| GeneOntologyCellularComponent | collagen network | 2.99e-08 | 8 | 18 | 3 | GO:0098645 | |
| GeneOntologyCellularComponent | basement membrane | 5.03e-08 | 122 | 18 | 5 | GO:0005604 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | 1.62e-07 | 530 | 18 | 7 | GO:0062023 | |
| GeneOntologyCellularComponent | extracellular matrix | 6.83e-07 | 656 | 18 | 7 | GO:0031012 | |
| GeneOntologyCellularComponent | external encapsulating structure | 6.97e-07 | 658 | 18 | 7 | GO:0030312 | |
| GeneOntologyCellularComponent | supramolecular polymer | 2.69e-03 | 1187 | 18 | 5 | GO:0099081 | |
| HumanPheno | Spinal instability | 1.52e-05 | 3 | 12 | 2 | HP:0005881 | |
| HumanPheno | Cervical instability | 1.52e-05 | 3 | 12 | 2 | HP:0008462 | |
| HumanPheno | Pretibial blistering | 3.04e-05 | 4 | 12 | 2 | HP:0012221 | |
| HumanPheno | Inflammatory abnormality of the eye | 8.87e-05 | 220 | 12 | 5 | HP:0100533 | |
| HumanPheno | Enlarged metaphyses | 1.06e-04 | 7 | 12 | 2 | HP:0003051 | |
| HumanPheno | Acetabular spurs | 1.41e-04 | 8 | 12 | 2 | HP:0010454 | |
| HumanPheno | Severe platyspondyly | 1.41e-04 | 8 | 12 | 2 | HP:0004565 | |
| HumanPheno | Abnormal corneal epithelium morphology | 1.81e-04 | 132 | 12 | 4 | HP:0011495 | |
| HumanPheno | Schizencephaly | 2.27e-04 | 10 | 12 | 2 | HP:0010636 | |
| MousePheno | buphthalmos | 5.58e-06 | 4 | 14 | 2 | MP:0009274 | |
| MousePheno | anterior polar cataract | 9.30e-06 | 5 | 14 | 2 | MP:0010259 | |
| MousePheno | polar cataract | 1.39e-05 | 6 | 14 | 2 | MP:0010258 | |
| MousePheno | macrophthalmia | 2.60e-05 | 8 | 14 | 2 | MP:0001296 | |
| MousePheno | dilated glomerular capillary | 3.34e-05 | 9 | 14 | 2 | MP:0011509 | |
| MousePheno | dilated capillary | 7.22e-05 | 13 | 14 | 2 | MP:0020326 | |
| MousePheno | total cataract | 7.22e-05 | 13 | 14 | 2 | MP:0010263 | |
| MousePheno | abnormal renal glomerular capsule morphology | 1.49e-04 | 107 | 14 | 3 | MP:0002828 | |
| MousePheno | hematuria | 1.58e-04 | 19 | 14 | 2 | MP:0005161 | |
| MousePheno | lens vacuoles | 1.75e-04 | 20 | 14 | 2 | MP:0011697 | |
| MousePheno | abnormal lens capsule morphology | 1.75e-04 | 20 | 14 | 2 | MP:0003236 | |
| MousePheno | abnormal grip strength | 1.77e-04 | 946 | 14 | 6 | MP:0001515 | |
| MousePheno | abnormal physical strength | 2.78e-04 | 1027 | 14 | 6 | MP:0004262 | |
| MousePheno | postnatal lethality | 3.74e-04 | 1084 | 14 | 6 | MP:0002082 | |
| MousePheno | abnormal kidney physiology | 4.00e-04 | 372 | 14 | 4 | MP:0002136 | |
| MousePheno | abnormal lens morphology | 4.23e-04 | 699 | 14 | 5 | MP:0001303 | |
| MousePheno | pale kidney | 4.83e-04 | 33 | 14 | 2 | MP:0004969 | |
| MousePheno | renal cast | 5.13e-04 | 34 | 14 | 2 | MP:0011402 | |
| MousePheno | abnormal hemoglobin content | 5.67e-04 | 408 | 14 | 4 | MP:0005563 | |
| MousePheno | kidney inflammation | 5.93e-04 | 171 | 14 | 3 | MP:0001859 | |
| MousePheno | podocyte foot process effacement | 6.41e-04 | 38 | 14 | 2 | MP:0008140 | |
| MousePheno | renal/urinary system inflammation | 6.88e-04 | 180 | 14 | 3 | MP:0011762 | |
| MousePheno | abnormal renal glomerulus basement membrane morphology | 8.60e-04 | 44 | 14 | 2 | MP:0011348 | |
| MousePheno | abnormal glomerular capillary morphology | 9.81e-04 | 47 | 14 | 2 | MP:0011320 | |
| MousePheno | abnormal kidney capillary morphology | 1.02e-03 | 48 | 14 | 2 | MP:0011310 | |
| MousePheno | abnormal eye development | 1.06e-03 | 482 | 14 | 4 | MP:0001286 | |
| MousePheno | stereotypic behavior | 1.14e-03 | 214 | 14 | 3 | MP:0001408 | |
| MousePheno | kidney atrophy | 1.25e-03 | 53 | 14 | 2 | MP:0004970 | |
| MousePheno | abnormal podocyte foot process morphology | 1.34e-03 | 55 | 14 | 2 | MP:0008059 | |
| MousePheno | abnormal renal tubule morphology | 1.35e-03 | 227 | 14 | 3 | MP:0002703 | |
| Domain | Collagen | 1.51e-12 | 85 | 19 | 7 | PF01391 | |
| Domain | Collagen | 1.51e-12 | 85 | 19 | 7 | IPR008160 | |
| Domain | C4 | 1.78e-08 | 6 | 19 | 3 | SM00111 | |
| Domain | - | 1.78e-08 | 6 | 19 | 3 | 2.170.240.10 | |
| Domain | Collagen_VI_NC | 1.78e-08 | 6 | 19 | 3 | IPR001442 | |
| Domain | NC1_IV | 1.78e-08 | 6 | 19 | 3 | PS51403 | |
| Domain | C4 | 1.78e-08 | 6 | 19 | 3 | PF01413 | |
| Domain | VWA | 2.39e-05 | 56 | 19 | 3 | PF00092 | |
| Domain | - | 5.53e-05 | 74 | 19 | 3 | 3.40.50.410 | |
| Domain | VWFA | 7.51e-05 | 82 | 19 | 3 | PS50234 | |
| Domain | VWA | 8.07e-05 | 84 | 19 | 3 | SM00327 | |
| Domain | VWF_A | 1.32e-04 | 99 | 19 | 3 | IPR002035 | |
| Domain | CTDL_fold | 1.66e-04 | 107 | 19 | 3 | IPR016187 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | 6.49e-15 | 41 | 15 | 7 | MM15538 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | 1.10e-14 | 44 | 15 | 7 | M27812 | |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | 1.25e-13 | 61 | 15 | 7 | MM14637 | |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | 2.48e-13 | 67 | 15 | 7 | M26999 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 6.20e-13 | 76 | 15 | 7 | MM14573 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 2.10e-12 | 90 | 15 | 7 | M631 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 7.13e-12 | 50 | 15 | 6 | MM14796 | |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 9.95e-12 | 20 | 15 | 5 | MM15061 | |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 1.03e-11 | 53 | 15 | 6 | MM14566 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 2.48e-11 | 61 | 15 | 6 | M27103 | |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 3.34e-11 | 64 | 15 | 6 | M26953 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 9.67e-11 | 76 | 15 | 6 | MM14867 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 1.93e-10 | 85 | 15 | 6 | M16441 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 3.19e-10 | 38 | 15 | 5 | MM14969 | |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 5.39e-10 | 42 | 15 | 5 | M7169 | |
| Pathway | PID_SYNDECAN_1_PATHWAY | 8.67e-10 | 46 | 15 | 5 | M198 | |
| Pathway | REACTOME_ANCHORING_FIBRIL_FORMATION | 1.13e-09 | 15 | 15 | 4 | M27161 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 1.16e-09 | 114 | 15 | 6 | MM14571 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 2.63e-09 | 57 | 15 | 5 | MM14713 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 2.88e-09 | 58 | 15 | 5 | M2049 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 3.60e-09 | 258 | 15 | 7 | MM14572 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 4.01e-09 | 140 | 15 | 6 | M587 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 4.40e-09 | 63 | 15 | 5 | M11187 | |
| Pathway | PID_INTEGRIN1_PATHWAY | 5.58e-09 | 66 | 15 | 5 | M18 | |
| Pathway | PID_AVB3_INTEGRIN_PATHWAY | 1.00e-08 | 74 | 15 | 5 | M160 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 1.03e-08 | 300 | 15 | 7 | M610 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 1.15e-08 | 76 | 15 | 5 | M27219 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 2.24e-08 | 30 | 15 | 4 | M27216 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 2.93e-08 | 32 | 15 | 4 | MM14924 | |
| Pathway | BIOCARTA_NPP1_PATHWAY | 1.16e-07 | 10 | 15 | 3 | M22040 | |
| Pathway | BIOCARTA_NPP1_PATHWAY | 1.16e-07 | 10 | 15 | 3 | MM1560 | |
| Pathway | BIOCARTA_VITCB_PATHWAY | 1.60e-07 | 11 | 15 | 3 | M15422 | |
| Pathway | BIOCARTA_VITCB_PATHWAY | 2.13e-07 | 12 | 15 | 3 | MM1526 | |
| Pathway | BIOCARTA_ACE2_PATHWAY | 2.77e-07 | 13 | 15 | 3 | MM1347 | |
| Pathway | BIOCARTA_ACE2_PATHWAY | 2.77e-07 | 13 | 15 | 3 | M12950 | |
| Pathway | BIOCARTA_PLATELETAPP_PATHWAY | 3.52e-07 | 14 | 15 | 3 | MM1458 | |
| Pathway | BIOCARTA_PLATELETAPP_PATHWAY | 3.52e-07 | 14 | 15 | 3 | M6487 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 3.65e-07 | 59 | 15 | 4 | M27218 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 4.40e-07 | 15 | 15 | 3 | MM14922 | |
| Pathway | REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS | 7.88e-07 | 18 | 15 | 3 | M27164 | |
| Pathway | REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS | 7.88e-07 | 18 | 15 | 3 | MM14882 | |
| Pathway | BIOCARTA_AMI_PATHWAY | 1.10e-06 | 20 | 15 | 3 | M15394 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 1.52e-06 | 84 | 15 | 4 | M7098 | |
| Pathway | BIOCARTA_INTRINSIC_PATHWAY | 1.70e-06 | 23 | 15 | 3 | M15997 | |
| Pathway | BIOCARTA_INTRINSIC_PATHWAY | 1.70e-06 | 23 | 15 | 3 | MM1427 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | 5.40e-06 | 261 | 15 | 5 | MM15676 | |
| Pathway | WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS | 1.17e-05 | 43 | 15 | 3 | M39565 | |
| Pathway | WP_PI3KAKT_SIGNALING | 1.92e-05 | 339 | 15 | 5 | M39736 | |
| Pathway | WP_FOCAL_ADHESION | 3.65e-05 | 187 | 15 | 4 | MM15913 | |
| Pathway | KEGG_FOCAL_ADHESION | 4.66e-05 | 199 | 15 | 4 | M7253 | |
| Pathway | WP_FOCAL_ADHESION | 4.66e-05 | 199 | 15 | 4 | M39402 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | 5.26e-05 | 418 | 15 | 5 | MM15587 | |
| Pathway | REACTOME_VESICLE_MEDIATED_TRANSPORT | 6.08e-05 | 725 | 15 | 6 | M27507 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | 1.25e-04 | 502 | 15 | 5 | MM14537 | |
| Pathway | WP_SMALL_CELL_LUNG_CANCER | 1.31e-04 | 96 | 15 | 3 | M39834 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | 1.65e-04 | 532 | 15 | 5 | M27870 | |
| Pathway | REACTOME_SCAVENGING_BY_CLASS_A_RECEPTORS | 1.79e-04 | 19 | 15 | 2 | M27221 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING | 2.34e-04 | 302 | 15 | 4 | M39719 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | 2.37e-04 | 575 | 15 | 5 | M29853 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTOR_SIGNALING_PATHWAY | 3.13e-04 | 326 | 15 | 4 | MM15917 | |
| Pathway | WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER | 6.01e-04 | 161 | 15 | 3 | M39770 | |
| Pathway | PID_INTEGRIN3_PATHWAY | 9.31e-04 | 43 | 15 | 2 | M53 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 1.11e-03 | 47 | 15 | 2 | MM14925 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | 2.42e-03 | 1432 | 15 | 6 | M509 | |
| Pathway | KEGG_SMALL_CELL_LUNG_CANCER | 3.50e-03 | 84 | 15 | 2 | M3228 | |
| Pathway | REACTOME_MEMBRANE_TRAFFICKING | 3.64e-03 | 630 | 15 | 4 | M11480 | |
| Pathway | REACTOME_VESICLE_MEDIATED_TRANSPORT | 3.96e-03 | 645 | 15 | 4 | MM15232 | |
| Pathway | REACTOME_RAB_GEFS_EXCHANGE_GTP_FOR_GDP_ON_RABS | 4.01e-03 | 90 | 15 | 2 | M27779 | |
| Pathway | REACTOME_RAB_GEFS_EXCHANGE_GTP_FOR_GDP_ON_RABS | 4.10e-03 | 91 | 15 | 2 | MM15518 | |
| Pathway | REACTOME_BINDING_AND_UPTAKE_OF_LIGANDS_BY_SCAVENGER_RECEPTORS | 4.74e-03 | 98 | 15 | 2 | M27152 | |
| Pathway | WP_SPINAL_CORD_INJURY | 5.72e-03 | 108 | 15 | 2 | MM15954 | |
| Pathway | WP_SPINAL_CORD_INJURY | 6.68e-03 | 117 | 15 | 2 | M39341 | |
| Pathway | REACTOME_RAB_REGULATION_OF_TRAFFICKING | 6.79e-03 | 118 | 15 | 2 | MM15589 | |
| Pathway | REACTOME_RAB_REGULATION_OF_TRAFFICKING | 7.25e-03 | 122 | 15 | 2 | M27872 | |
| Pathway | REACTOME_GOLGI_TO_ER_RETROGRADE_TRANSPORT | 8.31e-03 | 131 | 15 | 2 | MM15497 | |
| Pathway | REACTOME_GOLGI_TO_ER_RETROGRADE_TRANSPORT | 8.68e-03 | 134 | 15 | 2 | M27751 | |
| Pathway | WP_PLEURAL_MESOTHELIOMA | 1.03e-02 | 439 | 15 | 3 | M42563 | |
| Pathway | WP_CANCER_PATHWAYS | 1.52e-02 | 507 | 15 | 3 | M48302 | |
| Pathway | REACTOME_INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC | 1.67e-02 | 189 | 15 | 2 | MM15356 | |
| Pathway | REACTOME_INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC | 1.92e-02 | 203 | 15 | 2 | M27654 | |
| Pubmed | Proteomic characterization of human multiple myeloma bone marrow extracellular matrix. | 6.67e-13 | 62 | 19 | 6 | 28344315 | |
| Pubmed | Type VI collagen anchors endothelial basement membranes by interacting with type IV collagen. | 2.22e-12 | 7 | 19 | 4 | 9334230 | |
| Pubmed | 3.47e-12 | 175 | 19 | 7 | 28071719 | ||
| Pubmed | 4.45e-12 | 8 | 19 | 4 | 10382266 | ||
| Pubmed | 4.45e-12 | 8 | 19 | 4 | 3997552 | ||
| Pubmed | 1.56e-11 | 39 | 19 | 5 | 33580754 | ||
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | 7.96e-11 | 135 | 19 | 6 | 28675934 | |
| Pubmed | 2.45e-10 | 19 | 19 | 4 | 15689378 | ||
| Pubmed | 1.38e-09 | 5 | 19 | 3 | 9409248 | ||
| Pubmed | Insertional mutation of the collagen genes Col4a3 and Col4a4 in a mouse model of Alport syndrome. | 2.76e-09 | 6 | 19 | 3 | 10534397 | |
| Pubmed | Stimulation of extracellular matrix components in the normal brain by invading glioma cells. | 2.76e-09 | 6 | 19 | 3 | 9506531 | |
| Pubmed | 2.76e-09 | 6 | 19 | 3 | 7495302 | ||
| Pubmed | A tumor derived motility factor that stimulates cell migration on extracellular matrix. | 2.76e-09 | 6 | 19 | 3 | 9673377 | |
| Pubmed | 2.76e-09 | 6 | 19 | 3 | 2426947 | ||
| Pubmed | Angiogenesis and collagen type IV expression in different endothelial cell culture systems. | 2.76e-09 | 6 | 19 | 3 | 23551189 | |
| Pubmed | Monoclonal antibody to human basement membrane collagen type IV. | 2.76e-09 | 6 | 19 | 3 | 6811420 | |
| Pubmed | 2.76e-09 | 6 | 19 | 3 | 11732842 | ||
| Pubmed | Developmental distribution of collagen IV isoforms and relevance to ocular diseases. | 2.76e-09 | 6 | 19 | 3 | 19275937 | |
| Pubmed | 2.76e-09 | 6 | 19 | 3 | 6988303 | ||
| Pubmed | Immunolocalization of collagen types, laminin and fibronectin in the normal human pancreas. | 2.76e-09 | 6 | 19 | 3 | 6389236 | |
| Pubmed | 2.76e-09 | 6 | 19 | 3 | 12225806 | ||
| Pubmed | 4.83e-09 | 7 | 19 | 3 | 10639489 | ||
| Pubmed | 4.83e-09 | 7 | 19 | 3 | 7521231 | ||
| Pubmed | 4.83e-09 | 7 | 19 | 3 | 11711546 | ||
| Pubmed | Regulation of protease nexin-1 target protease specificity by collagen type IV. | 4.83e-09 | 7 | 19 | 3 | 8006028 | |
| Pubmed | 4.83e-09 | 7 | 19 | 3 | 10416788 | ||
| Pubmed | Hypoplastic basement membrane of the lens anlage in the inheritable lens aplastic mouse (lap mouse). | 4.83e-09 | 7 | 19 | 3 | 10716744 | |
| Pubmed | 4.83e-09 | 7 | 19 | 3 | 1724753 | ||
| Pubmed | 7.73e-09 | 8 | 19 | 3 | 29422532 | ||
| Pubmed | Discoidin domain receptor 1 functions in axon extension of cerebellar granule neurons. | 7.73e-09 | 8 | 19 | 3 | 10970885 | |
| Pubmed | 7.73e-09 | 8 | 19 | 3 | 1377218 | ||
| Pubmed | 1.16e-08 | 9 | 19 | 3 | 9878537 | ||
| Pubmed | 1.16e-08 | 9 | 19 | 3 | 8562707 | ||
| Pubmed | 1.16e-08 | 9 | 19 | 3 | 12101409 | ||
| Pubmed | 1.44e-08 | 50 | 19 | 4 | 23658023 | ||
| Pubmed | 1.65e-08 | 10 | 19 | 3 | 9136074 | ||
| Pubmed | 1.65e-08 | 10 | 19 | 3 | 9415455 | ||
| Pubmed | 2.27e-08 | 11 | 19 | 3 | 14998921 | ||
| Pubmed | Binding of mouse and human fibulin-2 to extracellular matrix ligands. | 2.27e-08 | 11 | 19 | 3 | 7500359 | |
| Pubmed | Sensory ataxia and muscle spindle agenesis in mice lacking the transcription factor Egr3. | 2.27e-08 | 11 | 19 | 3 | 9731539 | |
| Pubmed | 2.65e-08 | 167 | 19 | 5 | 22159717 | ||
| Pubmed | 3.03e-08 | 12 | 19 | 3 | 8918877 | ||
| Pubmed | Basement membrane fragility underlies embryonic lethality in fukutin-null mice. | 3.03e-08 | 12 | 19 | 3 | 15837576 | |
| Pubmed | Matrilin-2 interacts with itself and with other extracellular matrix proteins. | 3.03e-08 | 12 | 19 | 3 | 12180907 | |
| Pubmed | 3.03e-08 | 12 | 19 | 3 | 16024816 | ||
| Pubmed | Basal lamina molecules are concentrated in myogenic regions of the mouse limb bud. | 3.94e-08 | 13 | 19 | 3 | 9833687 | |
| Pubmed | 3.96e-08 | 64 | 19 | 4 | 22261194 | ||
| Pubmed | 5.01e-08 | 14 | 19 | 3 | 12878203 | ||
| Pubmed | 5.01e-08 | 14 | 19 | 3 | 19858219 | ||
| Pubmed | 6.26e-08 | 15 | 19 | 3 | 10625553 | ||
| Pubmed | 6.26e-08 | 15 | 19 | 3 | 9264260 | ||
| Pubmed | Inhibition of distal lung morphogenesis in Nkx2.1(-/-) embryos. | 6.26e-08 | 15 | 19 | 3 | 10706142 | |
| Pubmed | 7.71e-08 | 16 | 19 | 3 | 15878328 | ||
| Pubmed | Transcriptome-based systematic identification of extracellular matrix proteins. | 9.31e-08 | 79 | 19 | 4 | 18757743 | |
| Pubmed | 1.12e-07 | 18 | 19 | 3 | 9160753 | ||
| Pubmed | Comprehensive proteomic characterization of stem cell-derived extracellular matrices. | 1.31e-07 | 86 | 19 | 4 | 28327460 | |
| Pubmed | 1.83e-07 | 21 | 19 | 3 | 23325811 | ||
| Pubmed | 1.83e-07 | 21 | 19 | 3 | 27856617 | ||
| Pubmed | Glycoproteomics Reveals Decorin Peptides With Anti-Myostatin Activity in Human Atrial Fibrillation. | 2.13e-07 | 97 | 19 | 4 | 27559042 | |
| Pubmed | 2.83e-07 | 2 | 19 | 2 | 3597383 | ||
| Pubmed | 2.83e-07 | 2 | 19 | 2 | 17179069 | ||
| Pubmed | 2.83e-07 | 2 | 19 | 2 | 3200851 | ||
| Pubmed | 2.83e-07 | 2 | 19 | 2 | 32515830 | ||
| Pubmed | Sequence variants in COL4A1 and COL4A2 genes in Ecuadorian families with keratoconus. | 2.83e-07 | 2 | 19 | 2 | 21527998 | |
| Pubmed | COL4A2 mutations impair COL4A1 and COL4A2 secretion and cause hemorrhagic stroke. | 2.83e-07 | 2 | 19 | 2 | 22209247 | |
| Pubmed | 2.83e-07 | 2 | 19 | 2 | 39216230 | ||
| Pubmed | 2.83e-07 | 2 | 19 | 2 | 15583824 | ||
| Pubmed | 2.83e-07 | 2 | 19 | 2 | 22914737 | ||
| Pubmed | 2.83e-07 | 2 | 19 | 2 | 24317722 | ||
| Pubmed | 2.83e-07 | 2 | 19 | 2 | 31331924 | ||
| Pubmed | 2.83e-07 | 2 | 19 | 2 | 26006016 | ||
| Pubmed | 2.83e-07 | 2 | 19 | 2 | 30351356 | ||
| Pubmed | Mutations in Col4a1 cause perinatal cerebral hemorrhage and porencephaly. | 2.83e-07 | 2 | 19 | 2 | 15905400 | |
| Pubmed | 2.83e-07 | 2 | 19 | 2 | 24203695 | ||
| Pubmed | 2.83e-07 | 2 | 19 | 2 | 18706356 | ||
| Pubmed | 2.83e-07 | 2 | 19 | 2 | 3198626 | ||
| Pubmed | Intracerebral hemorrhage in a neonate with an intragenic COL4A2 duplication. | 2.83e-07 | 2 | 19 | 2 | 33247988 | |
| Pubmed | 2.83e-07 | 2 | 19 | 2 | 32413593 | ||
| Pubmed | 2.83e-07 | 2 | 19 | 2 | 11970952 | ||
| Pubmed | 2.83e-07 | 2 | 19 | 2 | 1630813 | ||
| Pubmed | Further refinement of COL4A1 and COL4A2 related cortical malformations. | 2.83e-07 | 2 | 19 | 2 | 30315939 | |
| Pubmed | 2.83e-07 | 2 | 19 | 2 | 26209635 | ||
| Pubmed | Prenatal clinical manifestations in individuals with COL4A1/2 variants. | 2.83e-07 | 2 | 19 | 2 | 32732225 | |
| Pubmed | 2.83e-07 | 2 | 19 | 2 | 33148145 | ||
| Pubmed | 2.83e-07 | 2 | 19 | 2 | 12011424 | ||
| Pubmed | 2.83e-07 | 2 | 19 | 2 | 2846280 | ||
| Pubmed | 2.83e-07 | 2 | 19 | 2 | 12021518 | ||
| Pubmed | 2.83e-07 | 2 | 19 | 2 | 3182844 | ||
| Pubmed | 2.83e-07 | 2 | 19 | 2 | 2844531 | ||
| Pubmed | 2.83e-07 | 2 | 19 | 2 | 29491144 | ||
| Pubmed | Genotype-phenotype correlations in pathology caused by collagen type IV alpha 1 and 2 mutations. | 2.83e-07 | 2 | 19 | 2 | 27794444 | |
| Pubmed | Do mutations in COL4A1 or COL4A2 cause thin basement membrane nephropathy (TBMN)? | 2.83e-07 | 2 | 19 | 2 | 17216253 | |
| Pubmed | 2.83e-07 | 2 | 19 | 2 | 34735964 | ||
| Pubmed | 2.83e-07 | 2 | 19 | 2 | 8317999 | ||
| Pubmed | Neurologic phenotypes associated with COL4A1/2 mutations: Expanding the spectrum of disease. | 2.83e-07 | 2 | 19 | 2 | 30413629 | |
| Pubmed | 2.83e-07 | 2 | 19 | 2 | 34281442 | ||
| Pubmed | Collagen alpha5 and alpha2(IV) chain coexpression: analysis of skin biopsies of Alport patients. | 2.83e-07 | 2 | 19 | 2 | 17554254 | |
| Pubmed | 2.83e-07 | 2 | 19 | 2 | 26343951 | ||
| Pubmed | Col4a1 mutations cause progressive retinal neovascular defects and retinopathy. | 2.83e-07 | 2 | 19 | 2 | 26813606 | |
| Pubmed | 3.57e-07 | 26 | 19 | 3 | 24742657 | ||
| Interaction | COLGALT2 interactions | 3.91e-09 | 67 | 19 | 5 | int:COLGALT2 | |
| Interaction | MMP9 interactions | 3.91e-09 | 67 | 19 | 5 | int:MMP9 | |
| Interaction | PLOD1 interactions | 5.42e-09 | 292 | 19 | 7 | int:PLOD1 | |
| Interaction | MMP2 interactions | 1.48e-08 | 87 | 19 | 5 | int:MMP2 | |
| Interaction | COL8A2 interactions | 6.17e-08 | 42 | 19 | 4 | int:COL8A2 | |
| Interaction | C1QTNF1 interactions | 9.81e-08 | 47 | 19 | 4 | int:C1QTNF1 | |
| Interaction | COL4A1 interactions | 1.07e-07 | 48 | 19 | 4 | int:COL4A1 | |
| Interaction | LAIR2 interactions | 1.16e-07 | 49 | 19 | 4 | int:LAIR2 | |
| Interaction | SERPINE2 interactions | 2.01e-07 | 56 | 19 | 4 | int:SERPINE2 | |
| Interaction | COL9A1 interactions | 2.02e-07 | 13 | 19 | 3 | int:COL9A1 | |
| Interaction | FBLN2 interactions | 3.92e-07 | 66 | 19 | 4 | int:FBLN2 | |
| Interaction | HABP2 interactions | 5.75e-07 | 18 | 19 | 3 | int:HABP2 | |
| Interaction | OSM interactions | 8.02e-07 | 20 | 19 | 3 | int:OSM | |
| Interaction | TGFBI interactions | 1.61e-06 | 25 | 19 | 3 | int:TGFBI | |
| Interaction | BGN interactions | 2.84e-06 | 30 | 19 | 3 | int:BGN | |
| Interaction | C1QTNF9 interactions | 5.41e-06 | 37 | 19 | 3 | int:C1QTNF9 | |
| Interaction | C1QC interactions | 7.97e-06 | 42 | 19 | 3 | int:C1QC | |
| Interaction | CD93 interactions | 9.83e-06 | 45 | 19 | 3 | int:CD93 | |
| Interaction | BMP3 interactions | 2.35e-05 | 8 | 19 | 2 | int:BMP3 | |
| Interaction | C1QTNF2 interactions | 2.59e-05 | 62 | 19 | 3 | int:C1QTNF2 | |
| Interaction | FN1 interactions | 9.23e-05 | 848 | 19 | 6 | int:FN1 | |
| Interaction | COL16A1 interactions | 1.28e-04 | 18 | 19 | 2 | int:COL16A1 | |
| Interaction | MATN2 interactions | 1.56e-04 | 113 | 19 | 3 | int:MATN2 | |
| Interaction | LYZL1 interactions | 1.77e-04 | 118 | 19 | 3 | int:LYZL1 | |
| Interaction | CFC1 interactions | 2.15e-04 | 126 | 19 | 3 | int:CFC1 | |
| Interaction | THBS1 interactions | 2.20e-04 | 127 | 19 | 3 | int:THBS1 | |
| Interaction | COL7A1 interactions | 2.49e-04 | 25 | 19 | 2 | int:COL7A1 | |
| Interaction | COL11A1 interactions | 3.37e-04 | 29 | 19 | 2 | int:COL11A1 | |
| Interaction | MAG interactions | 3.37e-04 | 29 | 19 | 2 | int:MAG | |
| Interaction | ANTXR2 interactions | 3.37e-04 | 29 | 19 | 2 | int:ANTXR2 | |
| Interaction | PDGFA interactions | 4.11e-04 | 32 | 19 | 2 | int:PDGFA | |
| Interaction | COLQ interactions | 4.37e-04 | 33 | 19 | 2 | int:COLQ | |
| Interaction | VEGFB interactions | 4.64e-04 | 34 | 19 | 2 | int:VEGFB | |
| Interaction | UST interactions | 5.80e-04 | 38 | 19 | 2 | int:UST | |
| Interaction | PLOD3 interactions | 6.41e-04 | 183 | 19 | 3 | int:PLOD3 | |
| Interaction | DCN interactions | 7.43e-04 | 43 | 19 | 2 | int:DCN | |
| Interaction | FEZ2 interactions | 8.14e-04 | 45 | 19 | 2 | int:FEZ2 | |
| Interaction | CHRNA1 interactions | 8.88e-04 | 47 | 19 | 2 | int:CHRNA1 | |
| Interaction | C1QTNF9B interactions | 1.04e-03 | 51 | 19 | 2 | int:C1QTNF9B | |
| Interaction | SAA1 interactions | 1.17e-03 | 54 | 19 | 2 | int:SAA1 | |
| Cytoband | 13q34 | 2.29e-04 | 54 | 19 | 2 | 13q34 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr13q34 | 6.08e-04 | 88 | 19 | 2 | chr13q34 | |
| GeneFamily | Collagens | 1.45e-15 | 46 | 14 | 7 | 490 | |
| Coexpression | NABA_COLLAGENS | 9.50e-16 | 43 | 19 | 7 | MM17060 | |
| Coexpression | NABA_COLLAGENS | 1.13e-15 | 44 | 19 | 7 | M3005 | |
| Coexpression | NABA_CORE_MATRISOME | 5.16e-10 | 270 | 19 | 7 | MM17057 | |
| Coexpression | NABA_CORE_MATRISOME | 5.87e-10 | 275 | 19 | 7 | M5884 | |
| Coexpression | HEBERT_MATRISOME_TNBC_LUNG_METASTASIS | 1.73e-09 | 23 | 19 | 4 | M48001 | |
| Coexpression | NABA_BASEMENT_MEMBRANES | 1.77e-08 | 40 | 19 | 4 | M5887 | |
| Coexpression | GU_PDEF_TARGETS_UP | 1.86e-07 | 71 | 19 | 4 | M3955 | |
| Coexpression | KANG_AR_TARGETS_UP | 2.18e-07 | 17 | 19 | 3 | M2223 | |
| Coexpression | KANG_AR_TARGETS_UP | 2.18e-07 | 17 | 19 | 3 | MM1297 | |
| Coexpression | DI_MARTINO_MATRISOME_HIGHLY_PROLIFERATIVE_HNSCC_TUMOR_CELL_DERIVED | 2.18e-07 | 17 | 19 | 3 | M47995 | |
| Coexpression | NABA_MATRISOME | 2.41e-07 | 1008 | 19 | 8 | MM17056 | |
| Coexpression | NABA_MATRISOME | 2.76e-07 | 1026 | 19 | 8 | M5889 | |
| Coexpression | DI_MARTINO_MATRISOME_HIGHLY_PROLIFERATIVE_HNSCC | 9.34e-07 | 27 | 19 | 3 | M47994 | |
| Coexpression | ROZANOV_MMP14_TARGETS_SUBSET | 1.74e-06 | 33 | 19 | 3 | M9167 | |
| Coexpression | WU_CELL_MIGRATION | 8.21e-06 | 183 | 19 | 4 | M2001 | |
| Coexpression | LEE_LIVER_CANCER_DENA_UP | 1.08e-05 | 60 | 19 | 3 | M16524 | |
| Coexpression | GSE43260_BTLA_POS_VS_NEG_INTRATUMORAL_CD8_TCELL_DN | 1.14e-05 | 199 | 19 | 4 | M9954 | |
| Coexpression | HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION | 1.17e-05 | 200 | 19 | 4 | M5930 | |
| Coexpression | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_16 | 2.47e-05 | 79 | 19 | 3 | M18400 | |
| Coexpression | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_16 | 2.56e-05 | 80 | 19 | 3 | MM1285 | |
| Coexpression | HEBERT_MATRISOME_TNBC_BONE_METASTASIS | 2.73e-05 | 11 | 19 | 2 | M47997 | |
| Coexpression | SWEET_KRAS_TARGETS_UP | 2.86e-05 | 83 | 19 | 3 | M2448 | |
| Coexpression | LIM_MAMMARY_LUMINAL_MATURE_DN | 4.15e-05 | 94 | 19 | 3 | M2580 | |
| Coexpression | LIM_MAMMARY_LUMINAL_MATURE_DN | 4.29e-05 | 95 | 19 | 3 | MM1328 | |
| Coexpression | QI_PLASMACYTOMA_DN | 4.70e-05 | 98 | 19 | 3 | M1852 | |
| Coexpression | QI_PLASMACYTOMA_DN | 4.99e-05 | 100 | 19 | 3 | MM775 | |
| Coexpression | HEVNER_TELENCEPHALON_VASCULAR_ENDOTHELIUM_AND_MENINGEAL_CELLS | 5.20e-05 | 15 | 19 | 2 | MM402 | |
| Coexpression | GAVIN_IL2_RESPONSIVE_FOXP3_TARGETS_UP | 8.45e-05 | 19 | 19 | 2 | M1739 | |
| Coexpression | GAVIN_IL2_RESPONSIVE_FOXP3_TARGETS_UP | 8.45e-05 | 19 | 19 | 2 | MM1219 | |
| Coexpression | FOROUTAN_INTEGRATED_TGFB_EMT_UP | 8.60e-05 | 120 | 19 | 3 | M42505 | |
| Coexpression | AIZARANI_LIVER_C33_STELLATE_CELLS_2 | 9.93e-05 | 126 | 19 | 3 | M39132 | |
| Coexpression | RUBENSTEIN_SKELETAL_MUSCLE_PERICYTES | 1.48e-04 | 144 | 19 | 3 | M41744 | |
| Coexpression | HU_FETAL_RETINA_FIBROBLAST | 1.49e-04 | 385 | 19 | 4 | M39264 | |
| Coexpression | HAY_BONE_MARROW_STROMAL | 1.75e-04 | 767 | 19 | 5 | M39209 | |
| Coexpression | NABA_MATRISOME_METASTATIC_LUNG_LYMPH_NODE_METASTASIS | 2.00e-04 | 29 | 19 | 2 | MM17055 | |
| Coexpression | CARRILLOREIXACH_HEPATOBLASTOMA_VS_NORMAL_HYPOMETHYLATED_AND_UP | 2.09e-04 | 162 | 19 | 3 | M45037 | |
| Coexpression | NABA_MATRISOME_METASTATIC_COLORECTAL_LIVER_METASTASIS | 2.14e-04 | 30 | 19 | 2 | M47990 | |
| Coexpression | YAMAZAKI_TCEB3_TARGETS_UP | 2.24e-04 | 166 | 19 | 3 | M1542 | |
| Coexpression | MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP | 2.32e-04 | 168 | 19 | 3 | M1124 | |
| Coexpression | TSAI_RESPONSE_TO_RADIATION_THERAPY | 2.44e-04 | 32 | 19 | 2 | M308 | |
| Coexpression | YAMAZAKI_TCEB3_TARGETS_UP | 2.80e-04 | 179 | 19 | 3 | MM660 | |
| Coexpression | GSE37301_HEMATOPOIETIC_STEM_CELL_VS_LYMPHOID_PRIMED_MPP_UP | 2.80e-04 | 179 | 19 | 3 | M8828 | |
| Coexpression | MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP | 2.94e-04 | 182 | 19 | 3 | MM993 | |
| Coexpression | ESC_V6.5_UP_LATE.V1_UP | 3.04e-04 | 184 | 19 | 3 | M2772 | |
| Coexpression | FOROUTAN_PRODRANK_TGFB_EMT_UP | 3.08e-04 | 185 | 19 | 3 | M42503 | |
| Coexpression | ESC_J1_UP_LATE.V1_UP | 3.13e-04 | 186 | 19 | 3 | M2768 | |
| Coexpression | FOROUTAN_TGFB_EMT_UP | 3.44e-04 | 192 | 19 | 3 | M42501 | |
| Coexpression | CARRILLOREIXACH_HEPATOBLASTOMA_VS_NORMAL_UP | 3.51e-04 | 891 | 19 | 5 | M45033 | |
| Coexpression | AIZARANI_LIVER_C21_STELLATE_CELLS_1 | 3.54e-04 | 194 | 19 | 3 | M39122 | |
| Coexpression | GSE26023_PHD3_KO_VS_WT_NEUTROPHIL_HYPOXIA_DN | 3.65e-04 | 196 | 19 | 3 | M8143 | |
| Coexpression | GSE20152_HTNFA_OVERXPRESS_ANKLE_VS_CTRL_SPHK1_KO_ANKLE_DN | 3.76e-04 | 198 | 19 | 3 | M7681 | |
| Coexpression | GSE21670_STAT3_KO_VS_WT_CD4_TCELL_IL6_TREATED_DN | 3.88e-04 | 200 | 19 | 3 | M7469 | |
| Coexpression | GSE16385_ROSIGLITAZONE_IL4_VS_ROSIGLITAZONE_ALONE_STIM_MACROPHAGE_UP | 3.88e-04 | 200 | 19 | 3 | M7986 | |
| Coexpression | CUI_DEVELOPING_HEART_CORONARY_VASCULAR_ENDOTHELIAL_CELL | 4.01e-04 | 41 | 19 | 2 | M39320 | |
| Coexpression | PILON_KLF1_TARGETS_UP | 4.13e-04 | 503 | 19 | 4 | M2226 | |
| Coexpression | GAO_LARGE_INTESTINE_ADULT_CJ_IMMUNE_CELLS | 4.19e-04 | 505 | 19 | 4 | M39167 | |
| Coexpression | VANHARANTA_UTERINE_FIBROID_UP | 4.62e-04 | 44 | 19 | 2 | M18274 | |
| Coexpression | BURTON_ADIPOGENESIS_4 | 4.84e-04 | 45 | 19 | 2 | M1605 | |
| Coexpression | BURTON_ADIPOGENESIS_4 | 5.06e-04 | 46 | 19 | 2 | MM1187 | |
| Coexpression | KHETCHOUMIAN_TRIM24_TARGETS_UP | 5.06e-04 | 46 | 19 | 2 | MM544 | |
| Coexpression | KHETCHOUMIAN_TRIM24_TARGETS_UP | 5.28e-04 | 47 | 19 | 2 | M1399 | |
| Coexpression | PILON_KLF1_TARGETS_UP | 5.44e-04 | 541 | 19 | 4 | MM1061 | |
| Coexpression | LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_DN | 5.50e-04 | 48 | 19 | 2 | M1246 | |
| Coexpression | BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_DN | 5.50e-04 | 48 | 19 | 2 | M10253 | |
| Coexpression | BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_DN | 5.50e-04 | 48 | 19 | 2 | MM1088 | |
| Coexpression | LINDGREN_BLADDER_CANCER_CLUSTER_3_DN | 5.53e-04 | 226 | 19 | 3 | M11238 | |
| Coexpression | BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_B | 5.94e-04 | 554 | 19 | 4 | M2244 | |
| Coexpression | HOSHIDA_LIVER_CANCER_SUBCLASS_S1 | 6.20e-04 | 235 | 19 | 3 | M5311 | |
| Coexpression | BROWNE_HCMV_INFECTION_30MIN_UP | 6.97e-04 | 54 | 19 | 2 | M6977 | |
| Coexpression | NABA_MATRISOME_PRIMARY_METASTATIC_COLORECTAL_TUMOR | 8.31e-04 | 59 | 19 | 2 | M47989 | |
| Coexpression | ZHENG_GLIOBLASTOMA_PLASTICITY_DN | 8.59e-04 | 60 | 19 | 2 | M1797 | |
| Coexpression | ZHENG_GLIOBLASTOMA_PLASTICITY_DN | 8.59e-04 | 60 | 19 | 2 | MM761 | |
| Coexpression | LEE_LIVER_CANCER_CIPROFIBRATE_UP | 8.59e-04 | 60 | 19 | 2 | M2195 | |
| Coexpression | ROZANOV_MMP14_TARGETS_UP | 8.98e-04 | 267 | 19 | 3 | M12890 | |
| Coexpression | AIZARANI_LIVER_C13_LSECS_2 | 1.06e-03 | 283 | 19 | 3 | M39117 | |
| Coexpression | DESCARTES_FETAL_HEART_SCHWANN_CELLS | 1.07e-03 | 67 | 19 | 2 | M40194 | |
| Coexpression | GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP | 1.10e-03 | 68 | 19 | 2 | M1373 | |
| Coexpression | PATIL_LIVER_CANCER | 1.14e-03 | 660 | 19 | 4 | M1195 | |
| Coexpression | GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP | 1.23e-03 | 72 | 19 | 2 | MM1131 | |
| Coexpression | FAN_EMBRYONIC_CTX_BRAIN_ENDOTHELIAL_2 | 1.29e-03 | 303 | 19 | 3 | M39040 | |
| Coexpression | LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_UP | 1.30e-03 | 74 | 19 | 2 | M515 | |
| Coexpression | TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN | 1.30e-03 | 74 | 19 | 2 | M13547 | |
| Coexpression | AIZARANI_LIVER_C9_LSECS_1 | 1.30e-03 | 304 | 19 | 3 | M39113 | |
| Coexpression | ODONNELL_METASTASIS_UP | 1.37e-03 | 76 | 19 | 2 | M265 | |
| Coexpression | HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS | 1.41e-03 | 77 | 19 | 2 | M19128 | |
| Coexpression | NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_DN | 1.41e-03 | 77 | 19 | 2 | M17937 | |
| Coexpression | FAN_OVARY_CL5_HEALTHY_SELECTABLE_FOLLICLE_THECAL_CELL | 1.48e-03 | 318 | 19 | 3 | M41707 | |
| Coexpression | MENON_FETAL_KIDNEY_3_STROMAL_CELLS | 1.56e-03 | 81 | 19 | 2 | M39253 | |
| Coexpression | ZHANG_UTERUS_C0_SECRETORY_STROMAL3_NPPC_HIGH_CELL | 1.75e-03 | 337 | 19 | 3 | MM16606 | |
| Coexpression | LAKE_ADULT_KIDNEY_C28_INTERSTITIUM | 1.75e-03 | 86 | 19 | 2 | M39247 | |
| Coexpression | KANG_IMMORTALIZED_BY_TERT_UP | 1.84e-03 | 88 | 19 | 2 | M5360 | |
| Coexpression | SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP | 1.98e-03 | 352 | 19 | 3 | M17471 | |
| Coexpression | LEE_BMP2_TARGETS_UP | 2.11e-03 | 780 | 19 | 4 | M2324 | |
| Coexpression | FAN_EMBRYONIC_CTX_BIG_GROUPS_BRAIN_ENDOTHELIAL | 2.20e-03 | 365 | 19 | 3 | M39018 | |
| Coexpression | LIU_PROSTATE_CANCER_UP | 2.32e-03 | 99 | 19 | 2 | M4619 | |
| Coexpression | LEE_BMP2_TARGETS_UP | 2.37e-03 | 805 | 19 | 4 | MM1067 | |
| Coexpression | MENON_FETAL_KIDNEY_9_ENDOTHELIAL_CELLS | 2.46e-03 | 102 | 19 | 2 | M39259 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_SMG_BASAL_CELL | 2.47e-03 | 380 | 19 | 3 | M45714 | |
| CoexpressionAtlas | dev gonad_e13.5_F_DevVascOvary_Flk_k-means-cluster#2_top-relative-expression-ranked_500 | 2.68e-05 | 66 | 19 | 3 | gudmap_dev gonad_e13.5_F_gudmap_devVascOvary_Flk_k2_500 | |
| CoexpressionAtlas | BM Top 100 - adipose tissue subcutaneous | 3.48e-05 | 72 | 19 | 3 | BM Top 100 - adipose tissue subcutaneous | |
| CoexpressionAtlas | BM Top 100 - adipose tissue omental | 3.78e-05 | 74 | 19 | 3 | BM Top 100 - adipose tissue omental | |
| CoexpressionAtlas | Mesoderm Day 5-reprogram_OSKM-L_vs_Mesoderm Day 5-reprogram_NA-Confounder_removed-fold2.0_adjp0.05 | 9.95e-05 | 281 | 19 | 4 | PCBC_ratio_MESO-5_from-OSKM-L_vs_MESO-5_from-ESC_cfr-2X-p05 | |
| CoexpressionAtlas | Mesoderm Day 5-method_mRNA_vs_Mesoderm Day 5-method_NA-Confounder_removed-fold2.0_adjp0.05 | 9.95e-05 | 281 | 19 | 4 | PCBC_ratio_MESO-5_from-mRNA_vs_MESO-5_from-ESC_cfr-2X-p05 | |
| CoexpressionAtlas | e9.5_OticVesic_top-relative-expression-ranked_500 | 3.70e-04 | 396 | 19 | 4 | Facebase_ST1_e9.5_OticVesic_500 | |
| CoexpressionAtlas | Mesoderm Day 5_vs_Pluripotent Stem Cells-Confounder_removed-fold2.0_adjp0.05 | 3.72e-04 | 1153 | 19 | 6 | PCBC_ratio_MESO-5_vs_SC_cfr-2X-p05 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.05e-10 | 182 | 19 | 6 | ed6ae0fd8653f213fe29906a6a4e0729a62e1b75 | |
| ToppCell | IPF-Epithelial-Aberrant_Basaloid|Epithelial / Disease state, Lineage and Cell class | 1.38e-08 | 189 | 19 | 5 | 4178be3292ff4a8a1d8098f638d4b8d15164d2c6 | |
| ToppCell | nucseq-Mesenchymal-Myocytic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.57e-08 | 194 | 19 | 5 | 2d66091097e106c7bee22e5281f50724700bdf8d | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.74e-08 | 198 | 19 | 5 | b086af292a508a156266c2d899ba1caf820bf61c | |
| ToppCell | Fetal_29-31_weeks|World / Lineage, Cell type, age group and donor | 1.78e-08 | 199 | 19 | 5 | 5b9d355795dd03a22f0961dfd143425c367a4654 | |
| ToppCell | Tracheal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.82e-08 | 200 | 19 | 5 | c318d14bd6fd6f42c597eb55ac9e2f48008aeb9b | |
| ToppCell | Hippocampus-Endothelial-ENDOTHELIAL_TIP-Dcn_1|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 5.59e-07 | 159 | 19 | 4 | 92049a8d8fc9997d8d0d76500c72596a9b2394e0 | |
| ToppCell | 21-Trachea-Epithelial-Submucosal_gland_basal|Trachea / Age, Tissue, Lineage and Cell class | 5.59e-07 | 159 | 19 | 4 | 4f670b57b8d3b090ea2f1aafe15baf93cb7ef146 | |
| ToppCell | AT1-AT2_cells-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 6.02e-07 | 162 | 19 | 4 | 57d627259d27f39885bf416d74bcb6656db6e27b | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.47e-07 | 171 | 19 | 4 | a4a2c5dc995589fbe3d4ca6ee1df888807e4ae34 | |
| ToppCell | Control-Fibroblasts-Pericytes|Control / group, cell type (main and fine annotations) | 7.47e-07 | 171 | 19 | 4 | 080003f698f867935c2bfc55d241d3650f45a0ab | |
| ToppCell | Endothelial-B-Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 7.64e-07 | 172 | 19 | 4 | 8a527dff06d841a86c7eb04a1dd9630787294da4 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.82e-07 | 173 | 19 | 4 | 5416b092321c7d9b63f0418c60f2402a138355bf | |
| ToppCell | 15-Trachea-Mesenchymal-Mesenchyme_RSPO2+|Trachea / Age, Tissue, Lineage and Cell class | 8.00e-07 | 174 | 19 | 4 | fa0681e91724b9a51ee28b214ea5aa14e62ba1a3 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-Mes-like-AT1_Progenitor|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.57e-07 | 177 | 19 | 4 | 164ffbbf798defa3728197deb1a14b661490e525 | |
| ToppCell | cellseq2-Mesenchymal-Myocytic-Myocytic_1-Pericyte|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.57e-07 | 177 | 19 | 4 | 68263456a3c93cd195b321b309ff59e156d732fe | |
| ToppCell | cellseq2-Mesenchymal-Myocytic-Myocytic_1|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.57e-07 | 177 | 19 | 4 | e415e448c37adc102d766235e9953dec32c021f1 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.16e-07 | 180 | 19 | 4 | fdbd7c22044d9328a1e06e2f9a4451529d1df767 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.16e-07 | 180 | 19 | 4 | 280ff5c8f292be1b88120db5ff1788b750644856 | |
| ToppCell | critical-Lymphoid-NK|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 9.16e-07 | 180 | 19 | 4 | 5abf778395392244daaec876f306ed7e4f388686 | |
| ToppCell | 18-Airway-Epithelial-Submucosal_gland_basal|Airway / Age, Tissue, Lineage and Cell class | 9.37e-07 | 181 | 19 | 4 | 33938e6521712058312879f84f4ae381c2bfc379 | |
| ToppCell | NS-critical-d_07-13-Lymphoid-NK|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 9.58e-07 | 182 | 19 | 4 | dd1c59babf7211362452e3e264009d70004d99f6 | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.58e-07 | 182 | 19 | 4 | fbd5e332df73bf7141c822fa67b76367dc962017 | |
| ToppCell | Adult-Mesenchymal-pericyte_cell-D122|Adult / Lineage, Cell type, age group and donor | 9.79e-07 | 183 | 19 | 4 | fc31a43a637423cb3bb9aa184a3a889a0b9aaea6 | |
| ToppCell | moderate-Lymphoid-NK|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.02e-06 | 185 | 19 | 4 | 4979a787acbc9b4ca8defe91cc79b674e51af1bf | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.02e-06 | 185 | 19 | 4 | a7dba7db79275884b2a93d8a16f2e0c739e71370 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.02e-06 | 185 | 19 | 4 | e58a009aaf342be019a909747b1895d5987d4daf | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.07e-06 | 187 | 19 | 4 | 86250acf088ec0c4800a0dfa031b0d4f7e52c342 | |
| ToppCell | Adult-Mesenchymal-pericyte_cell|Adult / Lineage, Cell type, age group and donor | 1.07e-06 | 187 | 19 | 4 | 62759efb660179402fb574ce5701c89a2e17bcfe | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.07e-06 | 187 | 19 | 4 | c104fbfef2d0bef64077ac721edf2379fd59d547 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.07e-06 | 187 | 19 | 4 | a2bf958ea59c359a265bfa437d59315e1920cdd4 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.09e-06 | 188 | 19 | 4 | 4d1e5f85342ae550086609d7680e32730b78b5d2 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.09e-06 | 188 | 19 | 4 | 997dcfc4f08738ab398d8abc15e4fd2fc6619862 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.09e-06 | 188 | 19 | 4 | ee151792c7ac9afe820f1a281c6dab383799f358 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_pericyte_(14)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.11e-06 | 189 | 19 | 4 | 9c2492c38f27e4c699b40680652e4c64911cce52 | |
| ToppCell | Mesenchymal-myofibroblast_cell|World / Lineage, Cell type, age group and donor | 1.11e-06 | 189 | 19 | 4 | 44e37f88137bb249933eb615235b2cf2ae7f3925 | |
| ToppCell | Mesenchymal-pericyte_cell|World / Lineage, Cell type, age group and donor | 1.11e-06 | 189 | 19 | 4 | d7ed96add29f219183c802895fbff519b627f635 | |
| ToppCell | moderate-Lymphoid-NK|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.11e-06 | 189 | 19 | 4 | 22a19365782003c18ec8dddcdbfdaa82c4e330f6 | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Mesenchymal|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.14e-06 | 190 | 19 | 4 | bd0d68dc1b6f388190a6ba8a83b011619abe2bdd | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.14e-06 | 190 | 19 | 4 | e275de94468872e70cf305b3b450823d4c9c5e3f | |
| ToppCell | Mesenchymal-airway_smooth_muscle_cell|World / Lineage, Cell type, age group and donor | 1.14e-06 | 190 | 19 | 4 | 645e56b02edc3702c7db917b8ecd5eed0decaf71 | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_1-Pericyte|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.14e-06 | 190 | 19 | 4 | 4eb92aef1ee868f4537483d19014d947b7684612 | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.14e-06 | 190 | 19 | 4 | 7be4341e2909101d756f14031c21e705eb45e69a | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.14e-06 | 190 | 19 | 4 | ee2f4a55d2fd18b83e55399b5b5697a15a2d2e70 | |
| ToppCell | 15-Trachea-Epithelial-Submucosal_gland_basal|Trachea / Age, Tissue, Lineage and Cell class | 1.16e-06 | 191 | 19 | 4 | 409e12d2bb26b6d2ed025304ca6ace07df16638a | |
| ToppCell | Mesenchymal-vascular_smooth_muscle_cell|World / Lineage, Cell type, age group and donor | 1.16e-06 | 191 | 19 | 4 | fd89fbc62aa1c73e0f659991e3bd726a0c97bd68 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.16e-06 | 191 | 19 | 4 | 716dfa7fccbd62b5f574792e68a26dc6c45511dc | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.16e-06 | 191 | 19 | 4 | 1626b23a57429f835fddc052e3c57f63a4e5b8bb | |
| ToppCell | LPS_only-Stromal_mesenchymal|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.18e-06 | 192 | 19 | 4 | 162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158 | |
| ToppCell | RV-01._Fibroblast_I|RV / Chamber and Cluster_Paper | 1.18e-06 | 192 | 19 | 4 | 356160b113c3305a61ceeaff33ce3c9da0be2878 | |
| ToppCell | ILEUM-inflamed-(8)_Smooth_muscle_cells|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.21e-06 | 193 | 19 | 4 | 084c88f08ce0ecd6c9f4334caed370eb2154f896 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.23e-06 | 194 | 19 | 4 | 3cffb5c58f6d5bd254f39ee9c41b7e1e4da0ff75 | |
| ToppCell | IPF-Stromal-Pericyte|World / Disease state, Lineage and Cell class | 1.23e-06 | 194 | 19 | 4 | 1a41da29d5adaf766a84eff0003b959e4523f7f1 | |
| ToppCell | COVID-19-lung-Pericytes/_Smooth_Muscle|lung / Disease (COVID-19 only), tissue and cell type | 1.23e-06 | 194 | 19 | 4 | 5e1e0513a54ec4cf0b247ec85c9fbc68dfac1da3 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.26e-06 | 195 | 19 | 4 | fee9d13f48149cd5f921cfe4b8b3053cf6a6dbd2 | |
| ToppCell | facs-Thymus-Thymus_Epithelium|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-06 | 196 | 19 | 4 | 6bc1187dfc4860a4e09032d7ea87ba3d9fe9f363 | |
| ToppCell | cellseq-Mesenchymal-Myocytic-Myocytic_1|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.29e-06 | 196 | 19 | 4 | c373465e34e2dd581247962d59e0477aae877079 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-06 | 196 | 19 | 4 | c8c89e469402e11aa2a9561e859b6fd1fb66c39b | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.29e-06 | 196 | 19 | 4 | 9d18381d7aaa063094a5df769a04c73350471525 | |
| ToppCell | IPF-Stromal-Pericyte|IPF / Disease state, Lineage and Cell class | 1.29e-06 | 196 | 19 | 4 | 8b6ff47ce5291d223f5e639fc45cd9267f418256 | |
| ToppCell | COVID-19-lung-Pericytes/_Smooth_Muscle|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.29e-06 | 196 | 19 | 4 | 754a3613340932563cd8424d775e18b93c3a1aaa | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.29e-06 | 196 | 19 | 4 | 12d9028f90c057c6e5cff00301793fa550e86c5a | |
| ToppCell | cellseq-Mesenchymal-Myocytic-Myocytic_1-Pericyte|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.29e-06 | 196 | 19 | 4 | 8b5337ccf74de90e8b89a02ac00671af1de2cfff | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.29e-06 | 196 | 19 | 4 | a52cb512c6173be92aa9c4d96e2abbc32f45478d | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.29e-06 | 196 | 19 | 4 | afddacc0fb8b9c73dad5333137deb471a6ebdc06 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Pericyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.31e-06 | 197 | 19 | 4 | 41dd312f46a2b983c8d864adeb6970c0ca4a8048 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Myofibroblastic-Muscle_perivascular_immune_recruiting|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.31e-06 | 197 | 19 | 4 | 3332b9b5bf78f0203ebbd94257a36e9054d896c3 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Pericyte-Muscle_pericyte_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.31e-06 | 197 | 19 | 4 | f66945f9007d59d4208849c7fd727f8519713fbc | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.31e-06 | 197 | 19 | 4 | 1da8ba5bbab232add6e43ad78b15c2339d0c2bc3 | |
| ToppCell | droplet-Bladder-BLADDER-1m-Epithelial-bladder_mesenchymal_cell_(Car3+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-06 | 197 | 19 | 4 | 86145bc1e585b4ae136e755cafd6579da2abfa65 | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.31e-06 | 197 | 19 | 4 | ac4f53acb2f8a428b0f2fab3c30a34e095a1bed7 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.31e-06 | 197 | 19 | 4 | 69fde2d27881f8408216e231c71cfdbd96f28d45 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.34e-06 | 198 | 19 | 4 | eb78b2ae6a787dbc75947e8dd5a03693285bc8be | |
| ToppCell | Parenchymal-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.34e-06 | 198 | 19 | 4 | bd42c03e384e64f61b02618cf1a5440033bb04b2 | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.34e-06 | 198 | 19 | 4 | c12e7511628db819a52959bb68580e27c00c2e41 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.34e-06 | 198 | 19 | 4 | 8b9e8eaeffda40912a0163fdf39b93bc5e64751c | |
| ToppCell | 3'-Child09-12-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.34e-06 | 198 | 19 | 4 | d83707b69fb64721ac3cff90ba58cdd999d6b386 | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.34e-06 | 198 | 19 | 4 | 22e766df1276c5b14aa0d83f434f47140ebb98ea | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.34e-06 | 198 | 19 | 4 | 21cf4d81386761d09d0f6829c01c198e5524176d | |
| ToppCell | Parenchymal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_systemic_arterial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.37e-06 | 199 | 19 | 4 | b768496381362f9a2706e0892b5a7a0db82e09ce | |
| ToppCell | Tracheal-NucSeq-Stromal-Peri/Epineurial_-NAF_epineurial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.37e-06 | 199 | 19 | 4 | 9c2db0bb94cba71a3cc1827844da090e213e0258 | |
| ToppCell | (02)_MMP9/10+|World / shred by cell type by condition | 1.37e-06 | 199 | 19 | 4 | 3f78eddeaa67d3b767aa38de765632166b09a4f0 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.37e-06 | 199 | 19 | 4 | ec74ff85d6b61013b1f785b2fca343759feb7843 | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 1.37e-06 | 199 | 19 | 4 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| ToppCell | (02)_MMP9/10+-(1)_GFP|(02)_MMP9/10+ / shred by cell type by condition | 1.37e-06 | 199 | 19 | 4 | 448ba982be804007f991d469eca9d885b21ae499 | |
| ToppCell | ILEUM-non-inflamed-(8)_Smooth_muscle_cells|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.37e-06 | 199 | 19 | 4 | 3368c0a90a47c4dcdfe70be3192550df0744e508 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 1.37e-06 | 199 | 19 | 4 | fde2b65afde69f402f1b7b056eaa266e9fd5b227 | |
| ToppCell | distal-mesenchymal-Pericyte-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.37e-06 | 199 | 19 | 4 | e72ac7a00405cde06293d7adac7dc40eb0cf87ba | |
| ToppCell | Tracheal-NucSeq-Stromal-Peri/Epineurial_|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.37e-06 | 199 | 19 | 4 | 3835452e4848d7f7dd8651c17b746b271ef39688 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts|LPS_only / Treatment groups by lineage, cell group, cell type | 1.37e-06 | 199 | 19 | 4 | 1a0add79f4e34078b3475eb11c85a4234bda197c | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Proliferating-Cycling_Progenitors|1_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.37e-06 | 199 | 19 | 4 | 358c4b3037f59378db8916a2fbe9ed4830cf1449 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic|LPS_only / Treatment groups by lineage, cell group, cell type | 1.37e-06 | 199 | 19 | 4 | 211c3a08f2d484ab7a3368006767289088f0d957 | |
| ToppCell | distal-mesenchymal-Pericyte-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.37e-06 | 199 | 19 | 4 | 000d9b5f5a48e56f0733390adb3d7270c49a4a1a | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.39e-06 | 200 | 19 | 4 | b4ccffdd79526c85e5273d27b668dbddcddba1ee | |
| ToppCell | proximal-3-mesenchymal-Pericyte|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.39e-06 | 200 | 19 | 4 | 98cbd0f4994e645f70c0bc5ebc1c3a3b28c6b67f | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Neuroepithelial-Proteoglycan-expressing_cell|10w / Sample Type, Dataset, Time_group, and Cell type. | 1.39e-06 | 200 | 19 | 4 | 07d2133c85e0a4eb8bef653ee15ecd0f1b2bbd44 | |
| ToppCell | distal-3-mesenchymal-Pericyte|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.39e-06 | 200 | 19 | 4 | 911db29f254bb697610e720ba78816e2c7f57933 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Pericyte-Pericyte_2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.39e-06 | 200 | 19 | 4 | 786f1ae53e60b5ffbf4bfd393d10b802478148b3 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.39e-06 | 200 | 19 | 4 | 67dcbd86fbc79fd585d0793f979e4aac100326c9 | |
| ToppCell | Bronchial-10x5prime-Stromal-Pericyte-Muscle_pericyte_pulmonary|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.39e-06 | 200 | 19 | 4 | 12326cc6f0af24bacba9493dc79e7c7347db2f41 | |
| Computational | Adhesion molecules. | 1.85e-05 | 141 | 13 | 4 | MODULE_122 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 2.62e-05 | 50 | 13 | 3 | GAVISH_3CA_MALIGNANT_METAPROGRAM_12_EMT_1 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 2.62e-05 | 50 | 13 | 3 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_2 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.60e-03 | 50 | 13 | 2 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_LIPID_METABOLISM | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.60e-03 | 50 | 13 | 2 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_PERICYTE_LIKE | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.60e-03 | 50 | 13 | 2 | GAVISH_3CA_METAPROGRAM_ENDOTHELIAL_ENDO_1 | |
| Computational | ECM and collagens. | 2.22e-03 | 225 | 13 | 3 | MODULE_47 | |
| Drug | GK-101 | 2.69e-13 | 36 | 19 | 6 | CID000161853 | |
| Drug | Madecassol | 1.29e-12 | 46 | 19 | 6 | CID000108062 | |
| Drug | d-indobufen | 2.18e-12 | 50 | 19 | 6 | CID000044562 | |
| Drug | ridogrel | 2.79e-12 | 52 | 19 | 6 | CID005362391 | |
| Drug | NSC49633 | 3.15e-12 | 53 | 19 | 6 | CID000023340 | |
| Drug | AC1LAKND | 8.39e-12 | 62 | 19 | 6 | CID000470146 | |
| Drug | PCR 4099 | 1.29e-11 | 139 | 19 | 7 | CID000002806 | |
| Drug | BAPN | 1.95e-11 | 71 | 19 | 6 | CID000001647 | |
| Drug | malotilate | 1.95e-11 | 71 | 19 | 6 | CID000004006 | |
| Drug | AC1NMZ1B | 2.73e-11 | 75 | 19 | 6 | CID005034185 | |
| Drug | strontium ranelate | 3.21e-11 | 77 | 19 | 6 | CID006918182 | |
| Drug | halofuginone lactate | 5.90e-11 | 85 | 19 | 6 | CID000062891 | |
| Drug | 4-hydroxyproline | 8.97e-11 | 91 | 19 | 6 | CID000000825 | |
| Drug | foscarnet | 1.17e-10 | 190 | 19 | 7 | CID000003414 | |
| Drug | ticlopidine | 1.91e-10 | 103 | 19 | 6 | CID000005472 | |
| Drug | hydroxylysine | 2.70e-10 | 109 | 19 | 6 | CID000001029 | |
| Drug | AC1L1C2F | 2.86e-10 | 110 | 19 | 6 | CID000001711 | |
| Drug | PPACK | 3.36e-10 | 113 | 19 | 6 | CID003036757 | |
| Drug | AC1L9732 | 3.55e-10 | 114 | 19 | 6 | CID000439300 | |
| Drug | Tranilast sodium | 3.74e-10 | 115 | 19 | 6 | CID000005527 | |
| Drug | Selara | 6.21e-10 | 125 | 19 | 6 | CID000150310 | |
| Drug | DMSe | 8.64e-10 | 132 | 19 | 6 | CID000020796 | |
| Drug | pirfenidone | 1.13e-09 | 138 | 19 | 6 | CID000040632 | |
| Drug | hyaluronan | 1.13e-09 | 263 | 19 | 7 | CID000024759 | |
| Drug | DL-penicillamine | 1.18e-09 | 139 | 19 | 6 | CID000004727 | |
| Drug | candesartan cilexetil | 1.52e-09 | 145 | 19 | 6 | CID000002540 | |
| Drug | L-lysyl-L-lysyl-L-lysine | 2.97e-09 | 162 | 19 | 6 | CID000072363 | |
| Drug | L-3,4-dehydroproline | 3.31e-09 | 73 | 19 | 5 | CID000094284 | |
| Drug | khellin | 4.11e-09 | 171 | 19 | 6 | CID000003828 | |
| Drug | AC1L18QD | 4.92e-09 | 325 | 19 | 7 | CID000000213 | |
| Drug | AC1L1DD6 | 5.41e-09 | 179 | 19 | 6 | CID000002299 | |
| Drug | 12(S)-hydroxyeicosatetraenoic acid | 7.49e-09 | 189 | 19 | 6 | CID000001413 | |
| Drug | AC1Q6PCP | 2.42e-08 | 230 | 19 | 6 | CID000005267 | |
| Drug | chondroitin sulfate | 2.56e-08 | 413 | 19 | 7 | CID000024766 | |
| Drug | prostacyclin sodium salt | 3.97e-08 | 250 | 19 | 6 | CID000000159 | |
| Drug | silibinin | 8.64e-08 | 285 | 19 | 6 | CID000005213 | |
| Drug | (2s,5s)-5-Carboxymethylproline | 1.53e-07 | 314 | 19 | 6 | CID000447989 | |
| Drug | losartan | 4.55e-07 | 378 | 19 | 6 | CID000003961 | |
| Drug | colchine | 4.91e-07 | 383 | 19 | 6 | CID000002833 | |
| Drug | LMWH | 6.39e-07 | 663 | 19 | 7 | CID000000772 | |
| Drug | Y-27632 | 1.16e-06 | 444 | 19 | 6 | CID000005711 | |
| Drug | AC1L1KMJ | 1.74e-06 | 476 | 19 | 6 | CID000030956 | |
| Drug | LS-63783 | 2.32e-06 | 804 | 19 | 7 | CID000000231 | |
| Drug | aspirin | 4.59e-06 | 563 | 19 | 6 | CID000002244 | |
| Drug | diphenylamine-2-carboxylate | 9.24e-06 | 164 | 19 | 4 | CID000004386 | |
| Drug | Succinic Acid | 1.84e-05 | 8 | 19 | 2 | ctd:D019802 | |
| Drug | 2-propylpentanoic acid; Down 200; 1000uM; HL60; HT_HG-U133A | 1.98e-05 | 199 | 19 | 4 | 6168_DN | |
| Drug | cyclophorine | 2.10e-05 | 426 | 19 | 5 | CID000002909 | |
| Drug | 4-aminoazobenzene | 2.18e-05 | 66 | 19 | 3 | CID000006051 | |
| Drug | 2-amino-4,6-dinitrotoluene | 2.60e-05 | 70 | 19 | 3 | ctd:C035208 | |
| Drug | dermatan sulfate | 2.93e-05 | 220 | 19 | 4 | CID000032756 | |
| Drug | 5-Acetamido-5,6-Dihydro-4-Hydroxy-6-Isobutoxy-4h-Pyran-2-Carboxylic Acid | 2.95e-05 | 73 | 19 | 3 | CID011963505 | |
| Drug | 8-azaguanine | 3.60e-05 | 78 | 19 | 3 | CID000008646 | |
| Drug | d 42 | 3.61e-05 | 11 | 19 | 2 | CID005288018 | |
| Drug | BMY-28100 | 5.12e-05 | 13 | 19 | 2 | CID000002646 | |
| Drug | Penicillins | 7.57e-05 | 100 | 19 | 3 | CID009548591 | |
| Drug | CAS 91832-40-5 | 1.37e-04 | 21 | 19 | 2 | CID006398970 | |
| Drug | tallimustine | 2.29e-04 | 27 | 19 | 2 | CID000065924 | |
| Drug | eniluracil | 2.29e-04 | 27 | 19 | 2 | CID000043157 | |
| Drug | Citric Acid | 2.64e-04 | 29 | 19 | 2 | ctd:D019343 | |
| Drug | thapsigargin; Down 200; 0.1uM; PC3; HT_HG-U133A | 4.22e-04 | 179 | 19 | 3 | 7103_DN | |
| Drug | 17-AAG; Up 200; 1uM; HL60; HT_HG-U133A | 4.22e-04 | 179 | 19 | 3 | 6184_UP | |
| Drug | ELAN | 4.32e-04 | 37 | 19 | 2 | CID000009469 | |
| Drug | sulfate | 4.72e-04 | 1292 | 19 | 6 | CID000001117 | |
| Drug | 4-aminopyrrolidine-2,4-dicarboxylate | 4.80e-04 | 39 | 19 | 2 | CID003331970 | |
| Drug | SC 19220; Down 200; 10uM; PC3; HT_HG-U133A | 5.18e-04 | 192 | 19 | 3 | 7065_DN | |
| Drug | LY 294002; Down 200; 10uM; HL60; HT_HG-U133A | 5.18e-04 | 192 | 19 | 3 | 2699_DN | |
| Drug | Progesterone [57-83-0]; Down 200; 12.8uM; PC3; HT_HG-U133A | 5.26e-04 | 193 | 19 | 3 | 6646_DN | |
| Drug | Estropipate [7280-37-7]; Down 200; 9.2uM; MCF7; HT_HG-U133A | 5.34e-04 | 194 | 19 | 3 | 6068_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; HL60; HT_HG-U133A | 5.34e-04 | 194 | 19 | 3 | 2672_DN | |
| Drug | Haloperidol [52-86-8]; Down 200; 10.6uM; PC3; HT_HG-U133A | 5.34e-04 | 194 | 19 | 3 | 4678_DN | |
| Drug | Streptozotocin [18883-66-4]; Down 200; 15uM; MCF7; HT_HG-U133A | 5.42e-04 | 195 | 19 | 3 | 6098_DN | |
| Drug | Promazine hydrochloride [53-60-1]; Down 200; 12.4uM; HL60; HT_HG-U133A | 5.42e-04 | 195 | 19 | 3 | 2173_DN | |
| Drug | 3-nitropropionic acid; Down 200; 10uM; MCF7; HT_HG-U133A | 5.50e-04 | 196 | 19 | 3 | 6367_DN | |
| Drug | estradiol, USP; Down 200; 0.01uM; ssMCF7; HG-U133A | 5.50e-04 | 196 | 19 | 3 | 373_DN | |
| Drug | 5194442; Up 200; 20uM; PC3; HT_HG-U133A | 5.50e-04 | 196 | 19 | 3 | 6594_UP | |
| Drug | Adamantamine fumarate [80789-67-9]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 5.50e-04 | 196 | 19 | 3 | 4806_UP | |
| Drug | 2-Aminobenzenesulfonamide [3306-62-5]; Up 200; 23.2uM; MCF7; HT_HG-U133A | 5.50e-04 | 196 | 19 | 3 | 3400_UP | |
| Drug | dimethylnitrosamine | 5.50e-04 | 196 | 19 | 3 | CID000006124 | |
| Drug | balofloxacin | 5.57e-04 | 42 | 19 | 2 | CID000065958 | |
| Drug | Fk 888 | 5.57e-04 | 42 | 19 | 2 | CID000107967 | |
| Drug | valdecoxib; Down 200; 10uM; PC3; HT_HG-U133A | 5.58e-04 | 197 | 19 | 3 | 6408_DN | |
| Drug | Fenofibrate [49562-28-9]; Up 200; 11uM; HL60; HT_HG-U133A | 5.58e-04 | 197 | 19 | 3 | 2401_UP | |
| Drug | Ciprofibrate [52214-84-3]; Up 200; 13.8uM; HL60; HT_HG-U133A | 5.58e-04 | 197 | 19 | 3 | 6138_UP | |
| Drug | Dizocilpine maleate [77086-22-7]; Down 200; 11.8uM; PC3; HT_HG-U133A | 5.58e-04 | 197 | 19 | 3 | 5746_DN | |
| Drug | Chlorzoxazone [95-25-0]; Down 200; 23.6uM; MCF7; HT_HG-U133A | 5.58e-04 | 197 | 19 | 3 | 2263_DN | |
| Drug | Napelline [5008-52-6]; Up 200; 11.2uM; HL60; HT_HG-U133A | 5.58e-04 | 197 | 19 | 3 | 2522_UP | |
| Drug | Diazoxide [364-98-7]; Down 200; 17.4uM; PC3; HT_HG-U133A | 5.58e-04 | 197 | 19 | 3 | 5810_DN | |
| Drug | 2-propylpentanoic acid; Down 200; 200uM; HL60; HT_HG-U133A | 5.58e-04 | 197 | 19 | 3 | 2674_DN | |
| Drug | Oxaprozin [21256-18-8]; Up 200; 13.6uM; MCF7; HT_HG-U133A | 5.66e-04 | 198 | 19 | 3 | 4352_UP | |
| Drug | 2-propylpentanoic acid; Down 200; 500uM; MCF7; HG-U133A | 5.66e-04 | 198 | 19 | 3 | 347_DN | |
| Drug | Glibenclamide [10238-21-8]; Down 200; 8uM; PC3; HT_HG-U133A | 5.66e-04 | 198 | 19 | 3 | 5849_DN | |
| Drug | sodium 4-phenylbutyrate; Down 200; 200uM; SKMEL5; HG-U133A | 5.66e-04 | 198 | 19 | 3 | 502_DN | |
| Drug | Benzylpenicillin sodium [69-57-8]; Up 200; 11.2uM; HL60; HT_HG-U133A | 5.75e-04 | 199 | 19 | 3 | 6155_UP | |
| Drug | Khellin [82-02-0]; Up 200; 15.4uM; HL60; HG-U133A | 5.75e-04 | 199 | 19 | 3 | 2004_UP | |
| Drug | Foliosidine [2520-38-9]; Up 200; 13uM; MCF7; HT_HG-U133A | 5.75e-04 | 199 | 19 | 3 | 3636_UP | |
| Drug | chlorpromazine hydrochloride; Up 200; 1uM; HL60; HT_HG-U133A | 5.75e-04 | 199 | 19 | 3 | 2677_UP | |
| Drug | Doxylamine succinate [562-10-7]; Up 200; 10.2uM; MCF7; HT_HG-U133A | 5.75e-04 | 199 | 19 | 3 | 1473_UP | |
| Drug | Alfadolone acetate [23930-37-2]; Up 200; 10.2uM; HL60; HT_HG-U133A | 5.83e-04 | 200 | 19 | 3 | 3127_UP | |
| Drug | phenytoin | 7.59e-04 | 219 | 19 | 3 | CID000001775 | |
| Disease | Developmental Porencephaly | 3.93e-07 | 2 | 19 | 2 | C4082301 | |
| Disease | Post-traumatic Porencephaly | 3.93e-07 | 2 | 19 | 2 | C3698507 | |
| Disease | Congenital porencephaly | 3.93e-07 | 2 | 19 | 2 | C0302892 | |
| Disease | Porencephaly | 3.93e-07 | 2 | 19 | 2 | C4082173 | |
| Disease | Porencephaly, Type 1, Autosomal Dominant | 3.93e-07 | 2 | 19 | 2 | C4551998 | |
| Disease | PORENCEPHALY, FAMILIAL | 3.93e-07 | 2 | 19 | 2 | C1867983 | |
| Disease | HEMORRHAGE, INTRACEREBRAL, SUSCEPTIBILITY TO | 3.93e-07 | 2 | 19 | 2 | C3281105 | |
| Disease | Hemorrhage, intracerebral, susceptibility to | 1.18e-06 | 3 | 19 | 2 | cv:C3281105 | |
| Disease | HEMORRHAGE, INTRACEREBRAL, SUSCEPTIBILITY TO | 1.18e-06 | 3 | 19 | 2 | 614519 | |
| Disease | Hematuria | 1.41e-05 | 9 | 19 | 2 | C0018965 | |
| Disease | collagen disease (implicated_via_orthology) | 2.58e-05 | 12 | 19 | 2 | DOID:854 (implicated_via_orthology) | |
| Disease | Pseudoaphakia | 1.08e-04 | 24 | 19 | 2 | C0524524 | |
| Disease | Lens Opacities | 1.08e-04 | 24 | 19 | 2 | C1510497 | |
| Disease | Nephrotic Syndrome | 1.37e-04 | 27 | 19 | 2 | C0027726 | |
| Disease | Cerebral Hemorrhage | 1.47e-04 | 28 | 19 | 2 | C2937358 | |
| Disease | spontaneous coronary artery dissection | 1.81e-04 | 31 | 19 | 2 | EFO_0010820 | |
| Disease | retinal detachment, retinal break | 2.31e-04 | 35 | 19 | 2 | EFO_0005773, EFO_0010698 | |
| Disease | Focal glomerulosclerosis | 2.44e-04 | 36 | 19 | 2 | C0017668 | |
| Disease | Cataract | 2.58e-04 | 37 | 19 | 2 | C0086543 | |
| Disease | platelet crit | 2.76e-04 | 952 | 19 | 5 | EFO_0007985 | |
| Disease | myopathy (implicated_via_orthology) | 4.35e-04 | 48 | 19 | 2 | DOID:423 (implicated_via_orthology) | |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | 5.31e-04 | 53 | 19 | 2 | C4707243 | |
| Disease | Small cell carcinoma of lung | 5.51e-04 | 54 | 19 | 2 | C0149925 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KGLRGIPGFAGADGG | 701 | P08572 | |
| DELGGRYGGPGGGER | 6 | Q00975 | |
| EGGGGGRKVGRYRDD | 441 | Q03468 | |
| GEEGKRGARGEPGGV | 486 | P02458 | |
| FPGERGEKGDRGFPG | 386 | P02462 | |
| GGEVGGLEFGKLPFG | 256 | Q15042 | |
| EGGGGGRKVGRYRDD | 441 | P0DP91 | |
| EYLRVGGRGGGKGKG | 256 | Q8N1G4 | |
| SGRGEGPGKKDDGRG | 1041 | Q9UKJ3 | |
| GGERGDGPNVKGEFL | 81 | Q5JUK9 | |
| GYPRLGGEGGKGGDV | 31 | A4D1E9 | |
| AGEGDKDGKPGIGFR | 276 | Q9ULE3 | |
| FRPIGGGAGGSGKEF | 636 | O43909 | |
| NGLPGFDGAGGRKGD | 1411 | P29400 | |
| GPRGPEGGRGDFGLK | 531 | P12110 | |
| EGGRGDFGLKGEPGR | 536 | P12110 | |
| GTRGEKGERGLDGFP | 596 | Q8NFW1 | |
| IGFPGERGLKGDRGD | 1996 | Q02388 | |
| EGLIGPKGDRGFDGQ | 2676 | Q02388 | |
| EDRPVGGRGFGGAGE | 281 | Q8NBJ4 | |
| EKRREGGGSGGGGEE | 381 | O15066 | |
| ARKGGGGPKDFGAGL | 6 | Q9Y5Y6 |